Funded by University of Michigan Comprehensive Cancer Center Research Grants Program
Funding Years: 2011-2012
Pilot study research aims:
- Develop and optimize procedures for future studies that elicit informed, deliberative views of cancer patients regarding disclosure preferences that should be included in informed consent for genome sequencing.
- Examine how a multi-disciplinary team of experts, Precision Medicine Tumor Board, determines which test results should be returned to cancer patients and clinicians, and how that information is received by referring clinicians.
- Develop and pilot interview guides to identify barriers to effective communication of sequencing results to patients.
J. Scott Roberts (PI), Raymond De Vries (Co-I), Scott Kim (Co-I), Brian Zikmund-Fisher (Co-I), Sameek Roychowdhury (Co-I)